Rascati K - Search Results

1

Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease.

Kang HA, Barner JC, Lawson KA, Rascati K, Mignacca RC. Kang HA, et al. Among authors: rascati k. Am J Hematol. 2023 Jan;98(1):90-101. doi: 10.1002/ajh.26765. Epub 2022 Nov 21. Am J Hematol. 2023. PMID: 36251408 Free article.

2

Ethnic differences in use of antipsychotic medication among Texas medicaid clients with schizophrenia.

Opolka JL, Rascati KL, Brown CM, Barner JC, Johnsrud MT, Gibson PJ. Opolka JL, et al. J Clin Psychiatry. 2003 Jun;64(6):635-9. doi: 10.4088/jcp.v64n0603. J Clin Psychiatry. 2003. PMID: 12823076

3

A descriptive analysis of asthma-related medical services and prescription utilization among recipients in a Medicaid program.

Smith MJ, Rascati KL, Barner JC. Smith MJ, et al. J Asthma. 2005 Jul-Aug;42(6):447-53. doi: 10.1081/JAS-67954. J Asthma. 2005. PMID: 16293539

4

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk.

Motsko SP, Rascati KL, Busti AJ, Wilson JP, Barner JC, Lawson KA, Worchel J. Motsko SP, et al. Drug Saf. 2006;29(7):621-32. doi: 10.2165/00002018-200629070-00007. Drug Saf. 2006. PMID: 16808554

5

Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas.

Yarger S, Rascati K, Lawson K, Barner J, Leslie R. Yarger S, et al. Among authors: rascati k. Clin Ther. 2008;30 Spec No:1051-7. doi: 10.1016/j.clinthera.2008.06.001. Clin Ther. 2008. PMID: 18640479

6

Antipsychotic medication utilization trends among Texas veterans: 1997-2002.

Yang M, Barner JC, Lawson KA, Rascati KL, Wilson JP, Crismon ML, Worchel J, Mascarenas CA. Yang M, et al. Ann Pharmacother. 2008 Sep;42(9):1229-38. doi: 10.1345/aph.1L155. Epub 2008 Aug 5. Ann Pharmacother. 2008. PMID: 18682544

7

Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.

Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Gavaza P, et al. Res Social Adm Pharm. 2011 Dec;7(4):369-82. doi: 10.1016/j.sapharm.2010.09.001. Epub 2010 Nov 5. Res Social Adm Pharm. 2011. PMID: 21272531

8

Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.

Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Gavaza P, et al. Br J Clin Pharmacol. 2011 Jul;72(1):143-52. doi: 10.1111/j.1365-2125.2011.03944.x. Br J Clin Pharmacol. 2011. PMID: 21332572 Free PMC article.

9

Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.

Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Gavaza P, et al. J Am Pharm Assoc (2003). 2011 May-Jun;51(3):397-403. doi: 10.1331/JAPhA.2011.10079. J Am Pharm Assoc (2003). 2011. PMID: 21555292

10

Use of antidepressant agents and the risk of type 2 diabetes.

Khoza S, Barner JC, Bohman TM, Rascati K, Lawson K, Wilson JP. Khoza S, et al. Among authors: rascati k. Eur J Clin Pharmacol. 2012 Sep;68(9):1295-302. doi: 10.1007/s00228-011-1168-3. Epub 2011 Nov 26. Eur J Clin Pharmacol. 2012. PMID: 22120432

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters